Search Results - Miyazaki, Yasumasa, M.D

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    The prognostic significance of OCT4 expression in patients with prostate cancer

    The prognostic significance of OCT4 expression in patients with prostate cancer by Kosaka, Takeo, M.D., Ph.D, Mikami, Shuji, M.D., Ph.D, Yoshimine, Shunsuke, M.D, Miyazaki, Yasumasa, M.D, Daimon, Tatsuaki, M.D, Kikuchi, Eiji, M.D., Ph.D, Miyajima, Akira, M.D., Ph.D, Oya, Mototsugu, M.D., Ph.D

    Published in Human pathology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model

    Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal... by Tanaka, Nobuyuki, M.D., Ph.D, Mizuno, Ryuichi, M.D., Ph.D, Yasumizu, Yota, M.D, Ito, Keiichi, M.D., Ph.D, Shirotake, Suguru, M.D., Ph.D, Masunaga, Ayako, M.D, Ito, Yujiro, M.D, Miyazaki, Yasumasa, M.D, Hagiwara, Masayuki, M.D, Kanao, Kent, M.D., Ph.D, Mikami, Shuji, M.D., Ph.D, Nakagawa, Ken, M.D., Ph.D, Momma, Tetsuo, M.D., Ph.D, Masuda, Takeshi, M.D, Asano, Tomohiko, M.D., Ph.D, Oyama, Masafumi, M.D., Ph.D, Oya, Mototsugu, M.D., Ph.D

    Published in Urologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: A multi-institutional study

    The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: A multi-institutional s... by Tanaka, Nobuyuki, M.D, Kikuchi, Eiji, M.D., Ph.D, Kanao, Kent, M.D., Ph.D, Matsumoto, Kazuhiro, M.D, Shirotake, Suguru, M.D, Kobayashi, Hiroaki, M.D, Miyazaki, Yasumasa, M.D, Ide, Hiroki, M.D, Obata, Jun, M.D, Hoshino, Katsura, M.D, Hayakawa, Nozomi, M.D, Kosaka, Takeo, M.D., Ph.D, Oyama, Masafumi, M.D., Ph.D, Miyajima, Akira, M.D., Ph.D, Momma, Tetsuo, M.D., Ph.D, Nakagawa, Ken, M.D., Ph.D, Jinzaki, Masahiro, M.D., Ph.D, Nakajima, Yosuke, M.D., Ph.D, Oya, Mototsugu, M.D., Ph.D

    Published in Urologic oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Prognostic significance of erythrocyte protein band 4.1-like5 expression in upper urinary tract urothelial carcinoma

    Prognostic significance of erythrocyte protein band 4.1-like5 expression in upper urinary tract urothelial carcinoma by Daimon, Tatsuaki, M.D, Kosaka, Takeo, M.D., Ph.D, Kikuchi, Eiji, M.D., Ph.D, Mikami, Shuji, M.D., Ph.D, Miyazaki, Yasumasa, M.D, Hashimoto, Ari, Ph.D, Hashimoto, Shigeru, Ph.D, Mizuno, Ryuichi, M.D., Ph.D, Miyajima, Akira, M.D., Ph.D, Okada, Yasunori, M.D., Ph.D, Sabe, Hisataka, Ph.D, Oya, Mototsugu, M.D., Ph.D

    Published in Urologic oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings

    Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings by Tanaka, Nobuyuki, M.D., Ph.D, Mizuno, Ryuichi, M.D., Ph.D, Shirotake, Suguru, M.D., Ph.D, Ito, Keiichi, M.D., Ph.D, Yasumizu, Yota, M.D, Masunaga, Ayako, M.D, Ito, Yujiro, M.D, Miyazaki, Yasumasa, M.D, Hagiwara, Masayuki, M.D, Kanao, Kent, M.D., Ph.D, Mikami, Shuji, M.D., Ph.D, Nakagawa, Ken, M.D., Ph.D, Momma, Tetsuo, M.D., Ph.D, Masuda, Takeshi, M.D, Asano, Tomohiko, M.D., Ph.D, Oyama, Masafumi, M.D., Ph.D, Oya, Mototsugu, M.D., Ph.D

    Published in Urologic oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Impact of second-line targeted therapy dose intensity on metastatic renal cell carcinoma patients

    Impact of second-line targeted therapy dose intensity on metastatic renal cell carcinoma patients by Shirotake, Suguru, M.D., Ph.D, Yasumizu, Yota, M.D, Ito, Keiichi, M.D., Ph.D, Masunaga, Ayako, M.D, Ito, Yujiro, M.D, Miyazaki, Yasumasa, M.D, Hagiwara, Masayuki, M.D, Kanao, Kent, M.D., Ph.D, Mikami, Shuji, M.D., Ph.D, Nakagawa, Ken, M.D., Ph.D, Momma, Tetsuo, M.D., Ph.D, Masuda, Takeshi, M.D, Asano, Tomohiko, M.D., Ph.D, Oyama, Masafumi, M.D., Ph.D, Tanaka, Nobuyuki, M.D., Ph.D, Mizuno, Ryuichi, M.D., Ph.D, Oya, Mototsugu, M.D., Ph.D

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: